EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Diamine Oxidase and Gastrointestinal Diseases

Paulina Żybul iD, Adam Przybyłkowski iD, Oksana Wojas iD, Bolesław Samoliński iD

Biomolecules · 05.08.2026 · 16 (8) · 1136

DOI: 10.3390/biom16081136 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Biomolecules, online erschienen am 05.08.2026. Verfasst von Paulina Żybul und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology and Internal Medicine, Medical University of Warsaw, 02-097 Warsaw, Poland. Hauptthemen laut MEDLINE: Amine Oxidase (Copper-Containing), Gastrointestinal Diseases. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 140 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Histamine plays an essential role in gastrointestinal physiology and immune control, while its balance in the intestinal environment is largely maintained through degradation by diamine oxidase (DAO), a copper-dependent enzyme mainly produced by differentiated enterocytes. Impaired DAO activity reduces the intestinal barrier to luminal histamine, leading to increased local and systemic exposure and contributing to altered motility, permeability, visceral sensitivity, and immune activation. Accumulating research suggests that disturbances in diamine oxidase regulation contribute to the development of various gastrointestinal diseases, including histamine intolerance, inflammatory and functional bowel disorders, intestinal ischemia, and liver pathology. This review summarizes current knowledge on the biochemistry, localization, and regulation of DAO, as well as histamine signalling via H1–H4 receptors in the gastrointestinal tract. We highlight the interaction between epithelial injury, immune activation, dysbiosis, and histamine accumulation, and discuss the divergent interpretation of mucosal versus circulating DAO activity. Finally, we critically assess the diagnostic limitations of serum DAO and explore emerging therapeutic strategies targeting impaired histamine degradation. Although DAO represents a promising adjunctive biomarker and therapeutic target, its clinical utility requires standardized measurement methods and integrative diagnostic approaches.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Amine Oxidase (Copper-Containing)Gastrointestinal DiseasesHumansHistamineAnimalsIntestinal Barrier FunctionIntestinal Mucosa

Stichwörter der Autor:innen

diamine oxidasegastrointestinal diseaseshistamine metabolismintestinal barrier

Substanzen

Amine Oxidase (Copper-Containing)Histamine

Autor:innen und Institutionen

  • Department of Gastroenterology and Internal Medicine, Medical University of Warsaw, 02-097 Warsaw, Poland.
  • Department of Prevention of Environmental Hazards Allergology and Immunology, Medical University of Warsaw, 02-097 Warsaw, Poland.

ORCID-Profile: Paulina Żybul, Adam Przybyłkowski, Oksana Wojas, Bolesław Samoliński

Zitieren

APA

Żybul, P., Przybyłkowski, A., Wojas, O., & Samoliński, B. (2026). Diamine Oxidase and Gastrointestinal Diseases. Biomolecules, 16(8), 1136. https://doi.org/10.3390/biom16081136

Vancouver

Żybul P, Przybyłkowski A, Wojas O, Samoliński B. Diamine Oxidase and Gastrointestinal Diseases. Biomolecules. 2026;16(8):1136. doi:10.3390/biom16081136

BibTeX
@article{ybul2026,
  author = {Żybul, Paulina and Przybyłkowski, Adam and Wojas, Oksana and Samoliński, Bolesław},
  title = {Diamine Oxidase and Gastrointestinal Diseases},
  journal = {Biomolecules},
  year = {2026},
  volume = {16},
  number = {8},
  pages = {1136},
  doi = {10.3390/biom16081136}
}
Kostenlos starten →